🌎 Tencent Music Entertainment Group Downgraded, The Wendy's Upgraded, Four Corners Property Trust Downgraded and more...

Ratings changes for Zentalis Pharmaceuticals, Black Diamond Therapeutics, McAfee, Neurocrine Biosciences, Target Hospitality, Silverback Therapeutics, Marqeta and more...Unsubscribe.

VIEW MY PORTFOLIO

August 18th, 2021

Like Getting In On Tesla at $10? (ad) Imagine if you'd bought shares of Tesla at $10 You'd be up 5,547% - enough to turn a starting stake of $1,000 into over $56,470! Well, Lou Basenese has found what he believes to be a "backdoor" for you to potentially get into "The Next Tesla"... For just $10! Could its earliest investors make a fortune? Click here to discover all the details about this private company - including its name - for free. Today's Top Stories It's Rally On For The TJX Companies Target extends streak even as online sales growth cools "3-Stock Retirement Blueprint" (ad) SmileDirectClub Is Only For the Most Risk-Tolerant Investors US stocks open lower, led by drops in health care, banks La-Z-Boy Vigorously Executing Growth Strategy With Success Housing construction slumps 7% in July to 1.53 million units Do You Trade Options? (ad) Sizing Up The Opportunity In Palantir (NYSE: PLTR) Target extends streak even as online sales growth cools CuriosityStream Stock is Poised to Breakout European stock markets slip, Asian markets advance Quick Links Today's MarketBeat Minute My MarketBeat Account Settings Mobile App Analyst Ratings Company Profiles Dividend Declarations Earnings Announcements Headlines Insider Trades Insider Buying Stocks Insider Selling Stocks 5 stocks that will get you through anything (ad) How do they do it? Because there is no substitute for what they sell. Everyone buys it, even when money is tight. Including you. You might cancel the Caribbean cruise, but you're not going to stop paying for this. That nonstop demand means they're kicking the tar out of other stocks. Since early 2000, they have posted a 1,636% total return, towering above the S&P 500's 195%. See the 5 stocks here. Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades The Andersons (NASDAQ:ANDE) was upgraded by analysts at Seaport Global Securities from a "neutral" rating to a "buy" rating.The current price is $31.01. Read More. BlackBerry (NYSE:BB) was upgraded by analysts at Canaccord Genuity from a "sell" rating to a "hold" rating. They now have a $10.00 price target on the stock.This represents a 0.9% downside from the current price of $10.09. Read More. Centennial Resource Development (NASDAQ:CDEV) was upgraded by analysts at Cowen Inc from an "underperform" rating to a "market perform" rating. They now have a $5.75 price target on the stock, up previously from $4.00.This represents a 28.3% upside from the current price of $4.48. Read More. Fuchs Petrolub (OTCMKTS:FUPBY) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating.The current price is $13.00. Read More. GEA Group Aktiengesellschaft (OTCMKTS:GEAGF) was upgraded by analysts at DZ Bank AG from a "sell" rating to a "hold" rating. They now have a €38.00 ($44.71) price target on the stock.The current price is $44.94. Read More. Glencore (OTCMKTS:GLNCY) was upgraded by analysts at AlphaValue from a "reduce" rating to a "buy" rating.The current price is $8.89. Read More. KS Aktiengesellschaft (OTCMKTS:KPLUY) was upgraded by analysts at AlphaValue from a "reduce" rating to a "buy" rating.The current price is $6.60. Read More. MedMen Enterprises (OTCMKTS:MMNFF) was upgraded by analysts at Cantor Fitzgerald from an "underweight" rating to a "neutral" rating. They now have a $0.30 price target on the stock.This represents a 12.6% upside from the current price of $0.27. Read More. NTT DATA (OTCMKTS:NTDTY) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating.The current price is $16.23. Read More. Shenandoah Telecommunications (NASDAQ:SHEN) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $41.00 price target on the stock.This represents a 32.7% upside from the current price of $30.90. Read More. Sunny Optical Technology (Group) (OTCMKTS:SNPTF) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $27.60. Read More. Splunk (NASDAQ:SPLK) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.The current price is $142.79. Read More. Subsea 7 (OTCMKTS:SUBCY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a 84.00 price target on the stock, down previously from 96.00.The current price is $7.56. Read More. ViacomCBS (NASDAQ:VIAC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $50.00 price target on the stock, up previously from $45.00.This represents a 21.7% upside from the current price of $41.10. Read More. Veoneer (NYSE:VNE) was upgraded by analysts at Credit Suisse Group AG from an "underperform" rating to a "neutral" rating. They now have a $37.00 price target on the stock, up previously from $17.00.This represents a 1.3% upside from the current price of $36.51. Read More. The Wendy's (NASDAQ:WEN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $29.00 price target on the stock.This represents a 19.7% upside from the current price of $24.22. Read More. View today's most recent analysts' upgrades at MarketBeat.com Tiny Biotech Wins $75 Billion Patent (ad) Cambridge firm proves its possible to "Find & Replace" cancer cells. The Wall Street Journal reports this small biotech is "Transforming Medicine." No wonder Goldman Sachs & Morgan Stanley have been quietly buying shares. Get the name of this little-known stock here >>> Analysts' Downgrades Ambu A/S (OTCMKTS:AMBBY) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $33.00. Read More. Ambu A/S (OTCMKTS:AMBBY) was downgraded by analysts at Nordea Equity Research from a "hold" rating to a "sell" rating.The current price is $33.00. Read More. Amcor (NYSE:AMCR) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $11.50 price target on the stock, down previously from $12.00.This represents a 5.4% downside from the current price of $12.16. Read More. Australia and New Zealand Banking Group (OTCMKTS:ANZBY) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $20.42. Read More. BP Midstream Partners (NYSE:BPMP) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $13.70 price target on the stock, down previously from $16.00.This represents a 5.7% upside from the current price of $12.96. Read More. Cree (NASDAQ:CREE) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $93.00 price target on the stock, down previously from $140.00.This represents a 16.4% upside from the current price of $79.88. Read More. Canadian Solar (NASDAQ:CSIQ) was downgraded by analysts at UBS Group AG from a "buy" rating to a "sell" rating. They now have a $18.00 price target on the stock.This represents a 47.8% downside from the current price of $34.50. Read More. CSL (OTCMKTS:CSLLY) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $108.07. Read More. Doman Building Materials Group (OTCMKTS:CWXZF) was downgraded by analysts at Canaccord Genuity from a "buy" rating to a "hold" rating.The current price is $5.95. Read More. SCREEN (OTCMKTS:DINRF) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.The current price is $97.00. Read More. Four Corners Property Trust (NYSE:FCPT) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $30.00 price target on the stock, down previously from $34.00.This represents a 10.3% upside from the current price of $27.21. Read More. Five9 (NASDAQ:FIVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $179.78. Read More. Fortis (NYSE:FTS) was downgraded by analysts at Industrial Alliance Securities from a "buy" rating to a "hold" rating. They now have a C$61.00 price target on the stock.The current price is $45.73. Read More. Medexus Pharmaceuticals (OTCMKTS:MEDXF) was downgraded by analysts at Canaccord Genuity from a "buy" rating to a "hold" rating.The current price is $2.27. Read More. Orchard Therapeutics (NASDAQ:ORTX) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $2.49. Read More. STORE Capital (NYSE:STOR) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $35.56. Read More. THK (OTCMKTS:THKLY) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $12.12. Read More. Tencent Music Entertainment Group (NYSE:TME) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $9.00 price target on the stock.This represents a 18.1% upside from the current price of $7.62. Read More. Tokyo Electron (OTCMKTS:TOELY) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.The current price is $100.20. Read More. View today's most recent analysts' downgrades at MarketBeat.com The Common Bacteria Fighting Cancer (ad) New breakthrough uses bacteria to "Find & Replace" cancer cells. 60 minutes calls this "the most consequential discovery in biomedicine." A Nobel Prize winner said, "This is no longer science fiction." Get the name of this little-known stock here >>> Analysts' New Coverage Chindata Group (NASDAQ:CD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $18.00 price target on the stock.This represents a 82.0% upside from the current price of $9.89. Read More. Core & Main (NYSE:CNM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $31.00 price target on the stock.This represents a 14.7% upside from the current price of $27.02. Read More. Enel (OTCMKTS:ENLAY) is now covered by analysts at Jefferies Financial Group Inc.. They set an "underperform" rating on the stock.The current price is $9.08. Read More. GXO Logistics (NYSE:GXO) is now covered by analysts at Loop Capital. They set a "buy" rating and a $90.00 price target on the stock.This represents a 17.0% upside from the current price of $76.92. Read More. Huntington Bancshares (NASDAQ:HBAN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.The current price is $14.79. Read More. MarketWise (NASDAQ:MKTW) is now covered by analysts at Raymond James. They set an "outperform" rating and a $15.00 price target on the stock.This represents a 51.4% upside from the current price of $9.91. Read More. Marqeta (NASDAQ:MQ) is now covered by analysts at Truist. They set a "buy" rating and a $37.00 price target on the stock.This represents a 45.2% upside from the current price of $25.48. Read More. Marqeta (NASDAQ:MQ) is now covered by analysts at Truist Securities. They set a "buy" rating and a $37.00 price target on the stock.This represents a 45.2% upside from the current price of $25.48. Read More. OneBeacon Insurance Group (NYSE:OB) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $25.00 price target on the stock.This represents a 49.3% upside from the current price of $16.74. Read More. Outset Medical (NASDAQ:OM) is now covered by analysts at Cowen Inc. They set an "outperform" rating and a $70.00 price target on the stock.This represents a 78.8% upside from the current price of $39.14. Read More. Pembina Pipeline (NYSE:PBA) (TSE:PPL) is now covered by analysts at Credit Suisse Group AG. They set a "neutral" rating on the stock.The current price is $31.29. Read More. REE Automotive (NASDAQ:REE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $20.00 price target on the stock.This represents a 100.0% upside from the current price of $10.00. Read More. View today's most recent analysts' new coverage at MarketBeat.com More Calendars from MarketBeat U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume. Upgrade Your Subscription Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2021 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.